acurapharm.comAbuse Deterrent Products by Acura Pharmaceuticals
acurapharm.com Profile
acurapharm.com
Title:Abuse Deterrent Products by Acura Pharmaceuticals
Description:Acura and King are developing Acurox® (oxycodone HCl) Tablets (without niacin) intended to relieve moderate to severe pain and to introduce limits and
Discover acurapharm.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
acurapharm.com Information
Website / Domain: |
acurapharm.com |
HomePage size: | 16.667 KB |
Page Load Time: | 0.135754 Seconds |
Website IP Address: |
184.168.207.1 |
Isp Server: |
GoDaddy.com LLC |
acurapharm.com Ip Information
Ip Country: |
United States |
City Name: |
Scottsdale |
Latitude: |
33.601974487305 |
Longitude: |
-111.88791656494 |
acurapharm.com Keywords accounting
acurapharm.com Httpheader
Date: Mon, 22 Jun 2020 20:29:24 GMT |
Server: Apache |
Vary: Accept-Encoding,Cookie |
Cache-Control: max-age=3, must-revalidate |
WP-Super-Cache: Served supercache file from PHP |
Content-Encoding: gzip |
Content-Length: 4216 |
Keep-Alive: timeout=5, max=100 |
Connection: Keep-Alive |
Content-Type: text/html; charset=UTF-8 |
acurapharm.com Meta Info
184.168.207.1 Domains
acurapharm.com Similar Website
Domain |
WebSite Title |
acurapharm.com | Abuse Deterrent Products by Acura Pharmaceuticals |
acura.niello.com | Cars for Sale | Acura Dealer Sacramento, CA | Niello Acura |
fv.acura.com | Acura Future Vehicles | Stay Informed | Acura.com |
acuracarland.com | Acura Carland | Acura Dealer in Duluth, GA |
acurabymcgrath.com | New and Used Acura Dealer | McGrath Acura of Westmont |
unitedkingdom.bacaworld.org | Bikers Against Child Abuse® United Kingdom – Breaking The Chains Of Abuse |
canada.bacaworld.org | Bikers Against Child Abuse Canada – Breaking The Chains Of Abuse |
washington.bacaworld.org | Bikers Against Child Abuse Washington – Breaking The Chains Of Abuse |
illinois.bacaworld.org | Bikers Against Child Abuse® Illinois – Breaking The Chains Of Abuse |
pennsylvania.bacaworld.org | Bikers Against Child Abuse Pennsylvania – Breaking The Chains Of Abuse |
arkansas.bacaworld.org | Bikers Against Child Abuse Arkansas – Breaking The Chains Of Abuse |
maryland.bacaworld.org | Bikers Against Child Abuse Maryland – Breaking The Chains Of Abuse |
iowa.bacaworld.org | Bikers Against Child Abuse Iowa – Breaking The Chains Of Abuse |
california.bacaworld.org | Bikers Against Child Abuse California – Breaking The Chains Of Abuse |
ohio.bacaworld.org | Breaking The Chains Of Abuse - Bikers Against Child Abuse |
acurapharm.com Traffic Sources Chart
acurapharm.com Alexa Rank History Chart
acurapharm.com Html To Plain Text
Home Company Need for Abuse Deterrent Products Platforms Technologies Technology Platforms AVERSION ® IMPEDE ® LIMITX ™ Market Opportunity Market Opportunity Partnerships Pfizer Advocacy Groups -- Advocacy Groups Patents Business Development Product Portfolio Pipeline Chart LIMITX ™ Products Under Development OXAYDO ® NEXAFED ® Product Line Important Safety Info Clinical Presentations -- Medical Meeting Calendar Clinical Studies -- Investors Investors Press Releases News & Events Corporate Governance Management Directors Committees ContactBoard Financial Information SEC Filings Quarterly Results Key Ratios Stock Information Historic Stock Lookup Investment Calculator Ownership Profile Risk Factors Contact Us acura Contact Us Company Need for Abuse Deterrent Products Platforms Company Overview Acura Pharmaceuticals, Inc. is an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. We have discovered and developed three proprietary platform technologies which can be used to develop multiple products. Our LIMITX ™ Technology is intended to minimize the risks and side effects associated with overdose by retarding the release of active drug ingredients when too many tablets are accidentally or purposefully ingested. Our AVERSION ® Technology is intended to address methods of product tampering associated with opioid abuse by incorporating gelling ingredients and irritants into tablets to discourage abuse by snorting and provide barriers to abuse by injection. Our IMPEDE ® Technology is directed at minimizing the extraction and conversion of pseudoephedrine tablets into methamphetamine. Our LIMITX ™ Technology, is currently in development with hydrocodone bitartrate and acetaminophen (also known as LTX-03) as the lead product candidate. This is due to the large market size and prevalence of oral excessive abuse and overdose. This technology is designed to retard the release of active opioid drug when too many tablets are accidentally or purposefully ingested by neutralizing stomach acid with buffer ingredients but deliver efficacious amounts of drug when taken as a single tablet with a nominal buffer dose. U.S. commercialization rights to LTX-03 are licensed to Abuse Deterrent Pharmaceuticals LLC. Our AVERSION ® Technology is licensed to Zyla Life Sciences (formerly known as Egalet Corporation) for use in OXAYDO ® Tablets (oxycodone HCl, CII), and is the first approved immediate-release oxycodone product in the United States with abuse deterrent labeling. OXAYDO ® is currently approved by the FDA for marketing in the United States in 5mg and 7.5mg strengths. Our IMPEDE ® Technology is used in Nexafed ® (30mg pseudoephedrine HCl) and Nexafed ® Sinus Pressure + Pain Tablets (pseudoephedrine HCl/acetaminophen 30/325mg tablets). We have licensed our Impede ® Technology to MainPointe Pharmaceuticals LLC for commercialization of these Nexafed ® products in the United States and Canada. Copyright © 1998-2019 Acura Pharmaceuticals. All rights reserved. Terms of Use and Privacy Policy Risk Factors Contact Us...
acurapharm.com Whois
"domain_name": "ACURAPHARM.COM",
"registrar": "TUCOWS, INC.",
"whois_server": "whois.tucows.com",
"referral_url": null,
"updated_date": [
"2020-02-12 17:16:41",
"2020-02-12T17:16:41"
],
"creation_date": [
"2004-03-29 17:48:56",
"2004-03-29T17:48:56"
],
"expiration_date": [
"2021-03-29 16:48:56",
"2021-03-29T16:48:56"
],
"name_servers": [
"NS51.DOMAINCONTROL.COM",
"NS52.DOMAINCONTROL.COM",
"ns51.domaincontrol.com",
"ns52.domaincontrol.com"
],
"status": "ok https://icann.org/epp#ok",
"emails": [
"domainabuse@tucows.com",
"support@verio-inc.com"
],
"dnssec": "unsigned",
"name": "REDACTED FOR PRIVACY",
"org": "REDACTED FOR PRIVACY",
"address": "REDACTED FOR PRIVACY",
"city": "REDACTED FOR PRIVACY",
"state": "Illinois",
"zipcode": "REDACTED FOR PRIVACY",
"country": "US"